Target intelligence / Profile preview

Streptococcus pneumoniae type 9N capsular polysaccharide (CPS 9N)

Target
CPS 9N
Molecular classification
Polysaccharide, Capsular Polysaccharide, Antigen
01

Overview

The Streptococcus pneumoniae type 9N capsular polysaccharide is a serotype-specific carbohydrate polymer forming the capsule of S. pneumoniae. It is a major virulence factor, protecting the bacterium from host immune responses. The repeating unit is a linear pentasaccharide: →4)-α-D-GlcpA-(1→3)-α-D-Glcp-(1→3)-β-D-ManpNAc-(1→4)-α-D-Glcp-(1→4)-β-D-GlcpNAc(1→. Type-specific immunity relies on recognition of unique epitopes on the capsule, making it a target for vaccines against pneumococcal disease.

Other names
Pneumococcal type 9N capsular polysaccharideS. pneumoniae serotype 9N capsuleType 9N CPS
02

Mechanism of action

Vaccines elicit type-specific antibodies that opsonize bacteria expressing the 9N capsule, promoting phagocytosis and clearance. Antibodies can also neutralize the capsule's antiphagocytic properties.

03

Biological functions

Immune evasionInhibition of phagocytosisInhibition of complement activationVirulence factor
04

Disease associations

PneumoniaMeningitisBacteremiaOtitis mediaSinusitisInfection
05

Safety considerations

Serotype replacement after vaccinationLimited serotype coverage of vaccines
06

Interacting drugs

Pneumococcal vaccines

1 more in the full profile.

07

Biomarkers

Capsular serotype in diagnosis of pneumococcal diseaseAntibody titers against type 9N CPS as a correlate of vaccine protection

Beyond the preview

Go deeper on Streptococcus pneumoniae type 9N capsular polysaccharide (CPS 9N).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae type 9N capsular polysaccharide (CPS 9N).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call